L10 Prostate Cancer

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/40

encourage image

There's no tags or description

Looks like no tags are added yet.

41 Terms

1
New cards

What is the incidence of prostate cancer?

2nd most common cancer, 2nd leading cause of cancer death in the US

  • 1 in 8 men will be dx w prostate cancer


2
New cards

Who are at high risk of prostate cancer?

  1. african american

  1. men w first degree relative dx with prostate cancer at age <65 yrs (african american x2 > caucasian > asian)


3
New cards

What are the genetic risk factors of prostate cancer?

tumor suppressor genes:

  • BRCA1/2 20-40% risk , 15% preval

  • TP53

ongogenes

  • BCR-ABL; HER2


4
New cards

What are the dietary risk factors of prostate cancer?

  • high meat and high fat intake

  • dec 1,25 dihydroxy vitamin D intake


5
New cards

African American men are at 2.5x higher risk of mortality from prostate cancer compared to non-Hispanic white men. BUT if there a difference when full adjust for other factors?

NO difference when fully adjusted for age, stage, insurance status, therapy received, socioeconomic status, access to healthcare

6
New cards

List social determinants assoc w prostate cancer mortality

  1. social support

  2. neighborhoods

  3. insurance status

  4. access to screening and healthcare

  5. adherence


7
New cards

describe the prostate gland

  1. located betw bladder and penis

    1. Urethra passes through the prostate

    2. Prostate gland cells produce seminal fluid, a glycoprotein that aids sperm motility

  2. growth is dependent on testosterone


8
New cards

Look at pathophys of prostate gland


9
New cards

Digital Rectal Exam (DRE) is not specific for prostate cancer and is not routinely recommended due to no evidence being beneficial for screening. What symptoms are consider normal and prostate cancer

normal: firm, but movable

prostate cancer: hard, lumps, inability to move

10
New cards

Prostate specific antigen (PSA) is a value used during prostate cancer screening. What value requires further evaluation? (not a cancer specific marker)

PSA >4ng/mL

11
New cards

Which drugs affect PSA?


12
New cards

NCCN screening recommendations


13
New cards

pt experiences symptoms such as difficult/painful/frequent urination, blood in urine or semen, impotence. What do they have?

localized prostate disease (otherwise usually asymptomatic)

14
New cards

pt experiences bone metastases (such as pain in back/hips/upper thighs, weakness/numbness in legs and feet from spinal cord, and fractures), lung or liver metastases. What do they have?

advanced/metastatic prostate disease

15
New cards

What is used for dx of prostate cancer?

  1. gold standard: prostate biopsy

  2. PSA

  3. genetic testing


16
New cards

What is involved in the work up of prostate cancer?

  1. Physical examination

  2. Digital rectal exam

  3. Estimate life expectancy

  4. PET/CT

  5. MRI

  6. PSMA PET


17
New cards

tumor grade is based on

most common histologies seen on biopsy

18
New cards

gleason score is

most common grade + second most common grade


19
New cards

prostate cancer staging is based on what?

  1. TNM staging:

    1. size of tumor (T)

    2. lymph node involvement (N)

    3. metastases present (M)

  2. PSA levels

  3. Gleason grade group


20
New cards

What are the 3 stages of prostate cancer?

  1. Localized (Any T, N0, M0)

  2. Regional (Any T, N1, M0)

  3. Metastatic (Any T, Any N, M1)


21
New cards

What is the initial treatment for localized/regional prostate cancer?

  1. observation or active surveillance

  2. radiation

  3. surgery

  4. androgen deprivation therapy (ADT)

    1. surgical castration

    2. pharm castration


22
New cards

What is the goal for observation vs active surveillance?

  1. observation: maintain quality of life by avoiding non-curative treatment

  2. active surveillance: actively monitoring expectation to deliver curative therapy if the cancer progresses (may act upon)


23
New cards

pt has low to favorable intermediate risk disease and a <10 year life expectancy. Should they undergo observation or active surveillance?

observation (preferred pts)

24
New cards

pt has low to favorable intermediate risk disease and a >=10 year life expectancy. Should they undergo observation or active surveillance?

active surveillance (preferred pts)

25
New cards

What should be monitored in observation vs active surveillance?

  1. observe: PSA, DRE, S every 12 mo

  2. act surveill: PSA no more than q6mo; DRE and biopsy no more than q12mo


26
New cards

What are the advantages of observation and active surveillance?

  1. avoid possible ADE assoc w treatment

  2. maintain quality of life


27
New cards

What are the disadvantages of observation?

  1. risk of progression of disease

  2. inc pt anxiety


28
New cards

What are the disadvantages of active surveillance ?

  1. missed opportunity for cure

  2. treatment delay

  3. icnreased pt anxiety


29
New cards

pt is in low risk group (OR favorable intermediate risk) and has a long life expectancy (>=10yrs) What should you treat them with?

  1. active surveillance

  2. radiation therapy (RT)

  3. radical prostalectomy (RP)


30
New cards

pt is in low risk group and has a short life expectancy (<10yrs) What should you treat them with?

observation

31
New cards

pt is in favorable intermediate risk group and has a short life expectancy (5-10yrs) What should you treat them with?

observation and RT

32
New cards

pt is in unfavorable intermediate risk group and has a long life expectancy (>10yrs) What should you treat them with?

  1. RP

  2. RT + androgen deprivation therapy (ADT) 4-6mo


33
New cards

pt is in high/very high risk group and has a long life expectancy (>5yrs or sympt) What should you treat them with?

  1. RT + ADT (1-3yrs)

  2. very high only: RT + ADT + abirateron (2yrs)

  3. RP ± pelvic lymph node disecction (PLND)


34
New cards

pt is in unfavorable intermediate risk group and has a short life expectancy (5-10yrs) What should you treat them with?

  1. RT + ADT (4-5 mo)

  2. observation


35
New cards

pt is in high/very high risk group and has a long life expectancy (<5yrs or asympt) What should you treat them with?

  1. observation

  2. RT ± ADT


36
New cards

pt has regional prostate cancer (any T, N1, M0) and has a long life expectancy (>5 yrs or sympt). How should you treat them?

  1. RT + ADT + abiraterone (2yrs)

  2. RT + ADT (2-3yrs)

  3. ADT ± abiraterone

  4. RP


37
New cards

pt has regional prostate cancer (any T, N1, M0) and has a short life expectancy (<=5 yrs or asympt). How should you treat them?

  1. RT ± ADT

  2. observation


38
New cards

radiation therapy is indicated for local, regional, and metastatic disease. What are the types of radiation?

  1. External beam radiation therapy

  2. Stereotactic body radiotherapy

  3. Internal radiation therapy

  4. Brachytherapy: radiation seeds injected into the prostate


39
New cards

What are the types of surgery?

  1. Radical prostatectomy

  2. Pelvic lymph node dissection


40
New cards

What are the ADE of radiation and surgery?

Frequent and obstructive urination, incontinence, abdominal cramping, bowel dysfunction, rectal bleeding, sexual dysfunction, proctitis

41
New cards